Loading today’s stories
Invest1 distinct publisher3 min readPublished
Washington has taken roughly $27 billion of ownership across about 30 companies since early 2025, an average near $900 million a position, so a challenge to the CHIPS Act equity conditions reaches well past Intel.
The Investor · Invest desk
Compiled by The InvestorSomething wrong?How this is made
The percentage is the headline and the consideration is the puzzle. Nearly $27 billion spread across about 30 transactions averages roughly $900 million a position [12], small enough that no single deal is systemically interesting and large enough that thirty of them are. The two stakes anyone can actually mark, 10% of Intel and 15% of MP Materials, came out of CHIPS Act funding and Defense Production Act authority [2], and those authorities were built to move money out the door rather than to accumulate shares [1]. That is the gap the Intel plaintiffs are standing in, arguing the legal basis for the equity demand is shaky enough that a finding in their favour could unwind some of the administration's most prominent deals [3].
"Unwind" is doing heavy lifting, and the reporting does not name a remedy [3]. If the equity was the price of a grant and the price turns out to have been unauthorised, a shareholder who wins gets the dilution reversed and someone still has to decide what happens to the cash that came with it. This is probably wrong, but the more interesting version of the outcome is not cancellation, it is renegotiation, with every later recipient of an equity-conditioned award holding a citation.
The soft numbers are softer than they look. In the Kent Clark survey, 67% of finance economists called government equity detrimental to corporate performance while 82% said it harms governance practices [5], a 15-point gap [14] that reads as respondents expecting the damage to show up in board process well before it shows up in the income statement. The July 2026 CNBC poll cited alongside it has 49% of voters calling the stakes inappropriate against 19% supportive [4], a 30-point margin [13] that also leaves 32 points of the sample expressing no view either way [15]. That is a weak mandate for repeal and a serviceable one for hearings.
Two objections are already on the congressional record: Rep. Pat Harrigan on the unintended consequences of holding equity in firms the government also regulates and contracts with [6], and Sen. Rick Scott describing state investment in private companies as a last-resort measure rather than a feature of industrial policy [7]. Neither needs the lawsuit to succeed to make the term expensive to write into the next award.
The allocation consequence is quieter than the legal one. Some institutional investors have begun carrying government-linked equity as its own risk category, keyed to election cycles and legislative calendars rather than earnings cycles and product roadmaps [11], which means analyst hours that went to fab yields and magnet offtake now go to counting votes. Those same investors took the announcement pop, since both Intel and MP Materials got a lift from the implied endorsement when the deals landed [8]. You cannot bid the endorsement and disown the litigation attached to it.
What would prove this desk wrong is unglamorous: a court finds the authority ample, the suit fails, and the equity condition becomes boilerplate priced at zero by the next disbursement cycle, leaving only the risk that arrives with an election [9]. Either way, the number worth holding is thirty, because one ruling on authority reaches all of them [1].
Ranked by verification strength, evidence, and original report placement.
Since early 2025 the Trump administration has executed roughly 30 equity and quasi-equity transactions totalling nearly $27 billion, converting federal grants and loan authorities into direct ownership stakes in private companies.
The US government holds a 10% equity stake in Intel and a 15% stake in MP Materials, both tied to CHIPS Act funding and the Defense Production Act.
An Intel shareholder lawsuit is challenging the legitimacy of the government's equity demands tied to CHIPS Act funding; plaintiffs argue the legal basis for those equity claims is shaky, and a finding upheld could unwind some of the administration's most prominent deals.
A July 2026 CNBC poll found 49% of voters view government ownership stakes in US companies as inappropriate, while 19% expressed support.
A Kent Clark survey found 67% of finance economists believe government equity stakes are detrimental to corporate performance, and 82% say government ownership harms governance practices.
Rep. Pat Harrigan has flagged what he calls "unintended consequences" when the government takes equity positions in firms it also regulates and contracts with.
Distinct publishers with included, body-backed reporting in this cluster.
cryptobriefing.com
1 article · August 29, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
invest
Yields rose, the dollar fell: Bessent's buybacks broke the offset allocators price1 distinct publisher
product
Micron puts about $1bn a year behind the claim that memory has been repriced for good2 distinct publishers
invest
The binding constraint on defense payouts is now an executive order1 distinct publisher
build
Glass-core substrates spent a billion dollars to arrive at package-level reliability evaluation1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Big numbers, no paper
Every figure that makes this story matter — the $27 billion, the ~30 deals, 49/19, 67/82 — comes from one outlet with no filing, dataset, poll release or survey link attached. The lawsuit that gives the piece its news value has no court and no docket, and the two lawmaker quotes are two words and three words long with no occasion attached.
Positions already on the books
Whatever the sourcing, this is not a proposal — two stakes are named and sized at 10% of Intel and 15% of MP Materials, and the reporting describes a portfolio built across roughly 30 completed transactions. That is real execution at scale; what keeps the score off the high end is that the count and the total have no register behind them and no third stake is even named.
Warning louder than the sourcing
The headline has market strategists warning and the closing section has institutional investors reclassifying government-linked equity as its own risk category — and not one strategist, fund or mandate is named. The share-price boost is asserted with no number attached, and the sharpest risk is a conditional about who controls Congress. The underlying facts are sturdier than the packaging: stakes in Intel and MP Materials need no amplification.
Nobody quoted is a neutral party
The visible motives run one direction. Shareholders suing to void equity conditions are litigating their own dilution; two Republican legislators putting daylight between themselves and the administration's industrial policy are doing politics in an election year; a finance-economist panel asked whether state ownership hurts governance is answering close to its own priors. Crypto Briefing does not weigh any of that, and the administration and companies get no line at all.
Directionally believable, individually uncheckable
That Washington holds equity in Intel and MP Materials and that it is being contested in court is plausible on its face and consistent with the statutes named. Our confidence is low anyway, because each number here is a single-outlet assertion and the pivotal items — docket, poll methodology, survey date — are exactly the ones missing. Treat the $900 million average as an accurate calculation on an unverified input.